Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor

NCT01694381 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: M5
DRUG: C1-inhibitor

Sponsor

TSI, LLC